The invention relates to compounds of the formula I 1
in which the radicals have the stated meanings, their stereoisomeric forms
and their physiologically tolerated salts and process for their
preparation.
The compounds are suitable for the treatment of metabohlic disorders such
as type 2 diabetes.
